Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Immupharma (IMM) Share Price

Price 2.595p on 30-05-2025 at 05:00:04
Change 0.00p 0%
Buy 0.00p
Sell 0.00p
Buy / Sell IMM Shares
Last Trade: Sell 5,000.00 at 2.54p
Day's Volume: 0
Last Close: 2.595p
Open: 0.00p
ISIN: GB0033711010
Day's Range 0.00p - 0.00p
52wk Range: 0.85p - 7.26p
Market Capitalisation: £11m
VWAP: 0.00p
Shares in Issue: 416m

Immupharma (IMM) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 5,000 2.54p SI Trade
16:28:00 - 29-May-25
Sell* 15,973 2.5415p Ordinary
16:19:43 - 29-May-25
Sell* 110,000 2.5415p Ordinary
16:16:30 - 29-May-25
Buy* 12,639 2.69p SI Trade
15:50:14 - 29-May-25
Sell* 5,000 2.54p SI Trade
15:50:14 - 29-May-25
Sell* 50,000 2.5483p Ordinary
15:40:38 - 29-May-25
Sell* 77,207 2.5483p Ordinary
15:23:59 - 29-May-25
Buy* 20,000 2.6749p Ordinary
14:52:25 - 29-May-25
Sell* 100 2.54p SI Trade
14:47:28 - 29-May-25
Sell* 125,000 2.60p Automatic Execution
14:47:28 - 29-May-25
See more Immupharma trades

Immupharma (IMM) Share Price History

Time period:
to
Date Open High Low Close Volume
29th May 2025 (Thu) 2.65 2.65 2.60 2.595 1,908,357
28th May 2025 (Wed) 2.75 2.75 2.70 2.70 1,849,648
27th May 2025 (Tue) 2.68 2.86 2.64 2.74 1,818,515
26th May 2025 (Mon) 2.605 2.605 2.605 2.605 0
23rd May 2025 (Fri) 2.60 2.65 2.60 2.655 2,346,024
22nd May 2025 (Thu) 2.83 2.83 2.65 2.71 2,895,585
21st May 2025 (Wed) 2.79 2.79 2.79 2.865 3,461,454
20th May 2025 (Tue) 2.84 2.84 2.68 2.855 4,726,666
19th May 2025 (Mon) 3.11 3.11 2.90 2.995 3,472,309
16th May 2025 (Fri) 3.435 3.435 3.355 3.355 505,969
15th May 2025 (Thu) 3.62 3.62 3.45 3.435 1,924,346
14th May 2025 (Wed) 3.34 3.70 3.34 3.455 2,851,797
13th May 2025 (Tue) 3.45 3.45 3.37 3.37 1,107,143
12th May 2025 (Mon) 3.34 3.70 3.14 3.45 2,856,141
9th May 2025 (Fri) 3.05 3.49 3.05 3.125 1,364,267
8th May 2025 (Thu) 2.94 2.95 2.94 2.975 1,502,342
7th May 2025 (Wed) 3.05 3.12 2.98 3.12 2,202,109
6th May 2025 (Tue) 3.21 3.35 3.01 3.135 2,307,344
5th May 2025 (Mon) 3.4435 3.4435 3.4435 3.4435 0
2nd May 2025 (Fri) 3.32 3.38 3.16 3.44 3,282,333
1st May 2025 (Thu) 4.00 4.00 3.20 3.505 8,786,903
30th Apr 2025 (Wed) 2.54 4.30 2.54 3.70 16,220,717
See more Immupharma price history

Immupharma (IMM) Regulatory News

Date Source Headline
27th May 2025 3:13 pm RNS Holding(s) in Company
20th May 2025 7:00 am RNS Notice of AGM
19th May 2025 7:00 am RNS Final Results
1st Apr 2025 7:00 am RNS Warrant Extension, Debt Conversion & Equity Issue
1st Apr 2025 7:00 am RNS Extension of Warrants in Incanthera to 30 Sep 2025
14th Mar 2025 7:00 am RNS-R IMM attending Bio-Europe Spring 17-19 March,Milan
13th Mar 2025 7:00 am RNS ImmuPharma proves unique Mechanism of Action-P140
21st Feb 2025 11:36 am RNS Holding(s) in Company
13th Feb 2025 7:00 am RNS £2.91m fundraising; related party transactions
28th Jan 2025 12:57 pm RNS Response to Share Price Movement
See more Immupharma regulatory news

Immupharma (IMM) Share News

Immupharma annual loss narrows as focused on clinical assets

19th May 2025 10:37

(Alliance News) - ImmuPharma PLC on Monday said its core anti-infective programme with antifungal and antibacterial candidates is progressing through pre-clinical studies, amid a narrowed loss. Read More

ImmuPharma celebrates "significant milestone" for P140 platform

13th Mar 2025 16:27

(Alliance News) - ImmuPharma PLC on Thursday announced "new discoveries" regarding the mechanism of action of its P140 autoimmune technology platform. Read More

AIM WINNERS & LOSERS: Hornby plots AIM exit; Ethernity deal progresses

13th Mar 2025 11:07

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More

IN BRIEF: ImmuPharma notes share price surge after novel findings

28th Jan 2025 14:28

ImmuPharma PLC - London-based specialist drug discovery and development company - Notes recent movements in its share price, as it has more than multiplied nearly five times higher in the last month to 6.03p per share, from 1.21p. The stock surged 94% higher in a single day in early January, to 2.33p, after ImmuPharma reported breakthrough findings in its preclinical research programme focused on P140 and the pathogenesis of autoimmune diseases. Read More

IN BRIEF: ImmuPharma shares climb on breakthrough autoimmune findings

9th Jan 2025 11:21

ImmuPharma PLC - London-based specialist drug discovery and development company - Says its preclinical research program focused on P140 and the pathogenesis of autoimmune diseases has yielded data that provides novel insights into autoimmune mechanisms. P140, the firms lead programme, is a unique non-immunosuppressive peptide for the treatment of systemic lupus erythematosus and chronic idiopathic demyelinating polyneuropathy. Adds that the findings, which were discovered by its R&D subsidiary ImmuPharma Biotech, pave the way for better diagnostics, identifying patients most likely to respond to P140 therapy and improved patient monitoring. Says the research marks a "significant step towards personalised medicine in SLE and other autoimmune diseases." Details of the data findings are not being released at this time since they form part of the ongoing expansion of the firms intellectual property portfolio. Read More

See more Immupharma news
FTSE 100 Latest
Value8,716.45
Change0.00

Login to your account

Forgot Password?

Not Registered